You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 Impact of patient-related and dose-volume-related factors on quality of life score changes

From: Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer - predictive factors on irritative symptoms, incontinence and rectal bleeding

  factor mean diff. (A-B) mean diff. (A-C) mean diff. (A-D)
bowel function score AUC-R≥50% 13 vs. 16 3 vs. 8 1 vs. 4†
  R70≥25% 15 vs. 16 4 vs. 12* 2 vs. 8*
  coronary heart disease 17 vs. 14 8 vs. 4† 3 vs. 3
  stroke in past history 10 vs. 15 3 vs. 5 7 vs. 3†
  chronic renal failure 30 vs. 15 15 vs. 5 11 vs. 3†
irritative function AUC-R≥50% 16 vs. 20 4 vs. 8 1 vs. 5†
  R70≥25% 18 vs. 18 5 vs. 13† 2 vs. 9†
  chronic renal failure 41 vs. 18 8 vs. 6 12 vs. 3†
incontinence function AUC-R≥50% 11 vs. 8 0 vs. 8† 2 vs. 6
  R70≥25% 10 vs. 8 3 vs. 12† 3 vs. 9†
rectal bleeding PTV≥300 cm3 4 vs. 4 2 vs. 2 4 vs. 0*
  NHT 4 vs. 4 3 vs. 2 0 vs. 4*
  coronary heart disease 6 vs. 3 5 vs. 1† 4 vs. 2
  haemorrhoids 12 vs. 4 7 vs. 2† 9 vs. 3†
  stroke in past history 0 vs. 4 0 vs. 2 10 vs. 3*
bowel bother score R70≥25% 19 vs. 27 8 vs. 22* 5 vs. 15*
  stroke in past history 9 vs. 20† 2 vs. 10 8 vs. 7
  chronic renal failure 37 vs. 19 11 vs. 10 21 vs. 6*
irritative bother AUC-R≥50% 10 vs.15† 8 vs. 11 6 vs. 7
  R70≥25% 22 vs. 31 10 vs. 26* 6 vs.16
  chronic renal failure 48 vs. 23 15 vs. 12 22 vs. 7*
incontinence bother R70≥25% 11 vs. 21 9 vs. 16 5 vs. 14†
rectal bleeding bother PTV≥300 cm3 4 vs. 6 2 vs. 4 5 vs. 0†
  coronary heart disease 7 vs. 3 5 vs. 2* 3 vs. 4
  1. only factors with significant impact on quality of life changes shown (actually significant differences marked with † p < 0.05 or *p < 0.01)